Lista de obras - Kathy Gately - Dominio Público Uruguay

A role for IGF-1R-targeted therapies in small-cell lung cancer?

artículo científico publicado en 2011

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response

artículo científico publicado en 2016

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo

artículo científico publicado en 2016

Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases.

artículo científico publicado en 2008

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells

artículo científico publicado en 2019

Design, construction, and analysis of cell line arrays and tissue microarrays for gene expression analysis.

artículo científico publicado en 2011

Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines.

artículo científico publicado en 2018

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.

artículo científico publicado en 2011

Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer

artículo científico publicado en 2017

Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma.

artículo científico publicado en 2013

High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.

artículo científico publicado en 2013

In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC

artículo científico publicado en 2016

Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes.

artículo científico publicado en 2007

Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: a verification study.

artículo científico publicado en 2011

PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer

scientific article published on 27 June 2011

Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function.

artículo científico publicado en 2007

Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project

artículo científico publicado en 2017

Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer.

artículo científico publicado en 2013

Prognostic impact of vascular and lymphovascular invasion in early lung cancer.

artículo científico publicado en 2013

Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer.

artículo científico publicado en 2011

RanGTPase: a candidate for Myc-mediated cancer progression.

artículo científico publicado en 2013

Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC.

artículo científico publicado en 2014

Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC.

artículo científico publicado en 2013

Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre.

artículo científico publicado en 2012

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

artículo científico publicado en 2013

Targeting the fibroblast growth factor receptor family in cancer.

artículo científico publicado en 2016

The establishment of an ISO compliant cancer biobank for Jordan and its neighboring countries through knowledge transfer and training.

scientific article published on February 2014

The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC.

artículo científico

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer

artículo científico publicado en 2014

Thymidine Phosphorylase in Cancer; Enemy or Friend?

artículo científico publicado en 2016

Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells.

artículo científico publicado en 2008

Tumor necrosis factor-alpha and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery

artículo científico publicado en 2006

Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.

artículo científico publicado en 2015

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.

artículo científico publicado en 2017

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer

artículo científico publicado en 2015

Lista de obras de Kathy Gately

A role for IGF-1R-targeted therapies in small-cell lung cancer?

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo

Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases.

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells

Design, construction, and analysis of cell line arrays and tissue microarrays for gene expression analysis.

Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines.

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.

Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer

Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma.

High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.

In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC

Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes.

Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: a verification study.

PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer

Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function.

Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project

Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer.

Prognostic impact of vascular and lymphovascular invasion in early lung cancer.

Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer.

RanGTPase: a candidate for Myc-mediated cancer progression.

Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC.

Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC.

Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre.

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

Targeting the fibroblast growth factor receptor family in cancer.

The establishment of an ISO compliant cancer biobank for Jordan and its neighboring countries through knowledge transfer and training.

The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC.

Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer

Thymidine Phosphorylase in Cancer; Enemy or Friend?

Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells.

Tumor necrosis factor-alpha and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery

Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.

Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer